Göran Tornling
Director/Miembro de la Junta en ACUCORT AB .
Origen de la red de primer grado Göran Tornling.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Karolinska Institutet
95
| College/University | Other Consumer Services | 95 |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
| Public Company | Pharmaceuticals: Major | 5 | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Göran Tornling a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
| University of Uppsala | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director/Board Member Chairman | |
| NEOS AB | Medical Specialties | Chief Executive Officer Director/Board Member Chairman Founder Founder | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Founder | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Founder | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Founder Corporate Officer/Principal | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| KANCERA AB | Pharmaceuticals: Major | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| University of Stockholm | College/University | Doctorate Degree Graduate Degree | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | President Founder | |
Din Bostad Sverige AB
 Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Real Estate Development | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
| KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President President | |
Fastilium Property Group AB
 Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Chief Executive Officer | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| Vetenskapsrådet | Director/Board Member Corporate Officer/Principal | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Gothenburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
| NANEXA AB | Medical Specialties | Director/Board Member Director/Board Member | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| CAMURUS AB | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Founder | |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Director/Board Member Chief Executive Officer | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
| VITROLIFE AB | Medical Specialties | Director/Board Member General Counsel | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Estadísticas
Internacional
| Suecia | 48 |
| Reino Unido | 2 |
| Estados Unidos | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 34 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Operativa
| Director/Board Member | 403 |
| Corporate Officer/Principal | 221 |
| Chairman | 115 |
| Independent Dir/Board Member | 77 |
| Founder | 74 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Göran Tornling
- Conexiones Empresas
